{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "84dad53b06adf57bb2615c8abc846760",
    "title": "GS EUROPEAN EXPRESS: Conviction | Wise | Geberit Holding | Macro | Global | Corporate Access",
    "source_uri": "2025-09-02/GS EUROPEAN EXPRESS_ Conviction List _ Wise _ Geberit Holding _ Macro _ Global _ Corporate Access_2025-09-02",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-27T00:21:21.276729",
      "extracted_at": "2025-10-27T00:21:21.276737"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 13,
        "successful_pages": 13,
        "date": "2025-09-02",
        "publication": "2025-09-02",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 1,
          "removed_paragraphs": 1,
          "reduction_ratio": 0.06175994017200548
        },
        "input_relative_path": "2025-09-02"
      }
    }
  },
  "passages": [
    {
      "passage_id": "f4161aa1b25e33b0",
      "text": "Click \"here\" to listen to the Europe Moving Call.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "7a3b7590b34a8f41",
      "text": "European Conviction List: Directors' Cut, September 2025 Update - We add UCB, Vestas Wind Systems and Konecranes to the Conviction List while removing L'Oreal.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "f97cb5e6ac99de5b",
      "text": "UCB: Bimzelx (câ‚¬7bn peak sales, \\(12\\%\\) ahead of consensus) is a rare opportunity within European Biopharma to own a significant blockbuster launch, per Rajan Sharma. He also sees optionality from other mid- stage drugs which could provide an additional leg of growth. Uncertainty around US pricing for the sector more widely provides an attractive entry point post UCB de- rating since the November 2024 peak to \\(22x\\) from \\(28x\\) on 12m forward P/E.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "9f4af3c6a5ac0301",
      "text": "Vestas: Ajay Patel highlights that as US energy policy uncertainty clears, Vestas is set for a positive order picture in 2H as well as an improvement in margins as the offshore drag has peaked. This improvement in 2H profitability should drive a sizeable increase in cash generation, strengthening the debate around cash returns.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "1d459e0fafcd196f",
      "text": "Konecranes: Daniela Costa sees a structural growth opportunity given Chinese tariffs and incentives for US reshoring, leaving significant upside risk to consensus. She also sees a recovery in Industrial Equipment over the medium term driven by German infrastructure spend (c20% of revenues). Strong cash generation supports increased returns with a total yield of c7%.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "fa77f9f984098121",
      "text": "Wise PLC (WISEA.L) - sizable Platforms opportunity underappreciated; Buy, on Conviction List - Mo Moawalla reiterates his Buy rating for Wise (on Conviction List) ahead of its key customer event focused on its Platforms business, Wise Connect in San Francisco on 10 Sept with a detailed c40pg note looking at different scenarios for Platforms out to 2040 and key debates like Stablecoin. He continues to see Platforms as a large, underappreciated opportunity, where Wise has reached an inflection point with Key recent wins (such as Nubank, Standard Chartered and Morgan Stanley). In his base case, he assumes the ramp up of existing partners only and his two upside scenarios assume 1) mid- term upside where he sees a faster ramp of existing partners (6- 14% PBT accretion vs base case 2026- 2030), and 2) long- term upside scenario where he assumes the faster ramp of existing plus future wins 2040E (c12- 30% PBT accretion). Mo's base case is already c5- 20% ahead of",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d4e06e2e925ea1ac",
      "text": "consensus 2028- 2030E underlying net income with upside risk to this in his view. He also looks at a reverse DCF to estimate that the share price is discounting low teens sales growth (vs. GSe of c16%) over the next decade which he thinks is undemanding. The Wise Connect event is the next catalyst to further support its healthy pipeline and more detail on recent wins. Buy with c45%+ upside.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "ae875834de357ae5",
      "text": "expansion within 5 years; Buy - Daniela Costa reiterates her Buy rating on Geberit post its 2Q results which were impacted by the reversal of pre- buying in 1Q. Daniela continues to expect an acceleration in European construction driven by German stimulus measures and market expectations of lower interest rates in 2026 which Geberit would benefit from. Geberit already scores above average on Daniela's screens (taken market share, top end on FCF margins) and could see further margin (and FCF) expansion over the coming years from the shower toilet business which continues to grow as part of the mix (Daniela estimates it its already \\(>10\\%\\) pa and could lead to a \\(>180bp\\) gross margin expansion over the next 5 years, detailed work in the note on shower toilets). Minor estimate adjustments post 2Q results \\(Europe EPS Changes (5% or more)Company NameForecast YearEPS % changeRatingPrice as of last closeBioArctic2025E9.0%BuySkr 309As of 5 AM UKT2026E30.0%",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "56913e38f1311a22",
      "text": "Source: Goldman Sachs Global Investment Research",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "b47b99438d01d85e",
      "text": "IAG (ICAG.L) - hosted investor meetings with IAG, overall message positive on trading and capital returns; Neutral",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "bbc2c1bf839535c9",
      "text": "Partners Group (PGHN.S) - Reported 2Q data on US- domiciled Evergreen funds, showing weaker inflows and step up in redemptions driving second quarter of net outflows for Master fund; Neutral",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "e9c9d67acd4ed379",
      "text": "BioArctic (BIOAb.ST) - Reported 2Q in- line, third BrainTransporter collaboration with Novartis provides additional step toward platform validation; updated PT with c14% upside; Buy",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "8e73274fd72eddf3",
      "text": "Global Weekly Kickstart - Markets stall as French politics weigh on Europe - Global equities were flat last week and Europe fell by 2% on political uncertainty in France. The CAC dropped 3.3%, reflecting concerns of a potential French government collapse in the",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "d69da58a0c024700",
      "text": "September 8 confidence vote. Macro data this week in Europe: August flash inflation prints for the Euro Area and Sweden, final PMI data for August across Europe, and July UK retail sales. Key policies and the speeches by BoE and Riksbank officials.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "7d2af1d0b0049bc0",
      "text": "US Court rules against tariffs pending Supreme Court review - The Court of Appeals for the Federal Circuit (AFC) largely upheld the Court of International Trade's (CIT) ruling blocking President Trump's tariffs under the International Economic Emergency Powers Act (IEEPA). The CAFC delayed the effect of its ruling until Oct. 14, or until the Supreme Court either declines to review the case or issues a judgement. If the Supreme Court agrees to review, the tariffs could remain in place until June 2026.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "478cf4122849c4e3",
      "text": "Consumer sentiment improves outside the Euro Area - Our economists update their G10 consumer dashboard for August highlighting that household balance sheet fundamentals remain strong, but sentiment and spending are subdued. Since the team last published the dashboard, sentiment improved in most economies but deteriorated in the Euro area.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "d1c49f839f56890f",
      "text": "Technical updates to our Global current activity indicators (CAIs) - Our economists update their proprietary tool to track economic activity, it has undergone three technical changes to improve their accuracy and correlation with historical GDP. These updates include substituting discontinued inputs, harmonising pandemic- affected months, and updating estimates of the relationship between business surveys and GDP.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "df8a240814a84813",
      "text": "APAC Conviction List - Directors' Cut September update - We add Eastroc, Disco, NYPCB, and Japan Exchange Group to the APAC Conviction List whilst removing MediaTek and Nari Tech.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "29748215155b8bc5",
      "text": "- Credit & Leveraged Finance Conference | 2 Sep | London | Financials | Today- European Medtech & Healthcare Services Conference | 3-4 Sep | London | Healthcare | Tomorrow- CEEMA Financials Symposium | 9-10 Sep | London | Financials- European Real Estate Equity & Debt Conference | 15 Sep | London | Real Estate- European Communacopia Conference | 16-17 Sep | London | TMT- German Corporate Conference | 22-24 Sep | Munich | Generalist- FinTech Conference | 7 Oct | London | Financials & Technology | Meeting Request Deadline Next Friday- Global Metals & Mining Conference | 14-15 Oct | London | Natural Resources | Meeting Request Deadline Next Friday- Carbonomics Conference | 12 Nov | London | Generalist / ESG | Save the Date- CEEMEA 1x1 Conference | 17-18 Nov | Generalist | Save the Date",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "1db409d0c505d1a1",
      "text": "Industrial & Autos Week | 1- 4 Dec | London | Industrials & Autos | Save the Date Digital Infrastructure Conference | 10 Dec | London | TMT | Save the Date",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "20f92551db7cb329",
      "text": "International Consolidated Airlines Group S.A. [IAG] | 2- 3 Sep | London | CEO, CFO Flutter Entertainment Plc [FLUT/FLTR LN] | 11 Sep | Denver | IR",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "d8f15a6fe6224ee2",
      "text": "Global Retailing Conference | 3- 4 Sep | New York | Conference",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "3c984ca67918392a",
      "text": "Energy & Natural Resources",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "db96678002f9f890",
      "text": "Veolia Environnement | 4 Sep | London | CEO, CFO, IR Repsol SA [REP SM] | 24 Sep | New York | Deputy CEO, IR Global Metals & Mining Conference | 14- 15 Oct | London | Natural Resources | Meeting Request Deadline Next Friday Carbonomics Conference | 12 Nov | London | Conference | Save the Date",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "3be2132f68c9f04c",
      "text": "Financials & Real Estate",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "8119f6ebcfff352e",
      "text": "European Financials Fieldtrip | 1 Sep (Frankfurt), 2 Sep (Milan) | Financials Credit & Leveraged Finance Conference | 2 Sep | London | Conference | Today M&G Plc [MNG L] | 4,18 Sep (London), 5 Sep (Virtual) | CEO, CFO CEEMA Financials Symposium | 9- 10 Sep | London | Financials Brookfield Business Partners [BBU] | 11 Sep | London | Managing Partner & CFO in Brookfield's Private Equity Group, IR Spanish Banks Fieldtrip | 12 Sep | Madrid | Financials European Real Estate Equity & Debt Conference | 15 Sep | London | Conference Aberdeen Group [ABDN L] | 16, 18 Sep | Virtual | CEO, CFO ICG Plc [ICGIN L] | 6 Oct (Netherlands), 7 Oct (Helsinki), 8 Oct (Stockholm), 9 Oct (Copenhagen) | Head of Corporate Development & IR FinTech Conference | 7 Oct | London | Financials & Technology | Meeting Request Deadline Next Friday",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "68337bf88b00dd4f",
      "text": "European Medtech & Healthcare Services Conference | 3- 4 Sep | London | Healthcare | This Week CSL Ltd | 4 Sep (Edinburgh) | CEO, IR",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "77ab333fe6238afd",
      "text": "Communacopia + Technology Conference | 8- 11 Sep | San Francisco | Technology EMEA Technology Investors Bus Tour | 10- 12 Sep | San Francisco, CA | Field Trip",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "57d60dcd55fc49cb",
      "text": "Inventec|15 Sep | London | CFO, IR European Communacopia Conference | 16- 17 Sep | London | Conference FinTech Conference | 7 Oct | London | Financials & Technology | Meeting Request Deadline Next Friday",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "b057c5b86eea45b6",
      "text": "Please visit our \"Events\" page for a complete list of calls and events around the globe",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "db5bfa1d51e52639",
      "text": "TODAY: 15th Annual EMEA Credit and Leveraged Finance Conference | London | Visit Conference Website September 3- 4th: 32nd Annual Global Retailing Conference | New York | Visit Conference Website September 3- 4th: European Medtech & Healthcare Services Conference | London | Visit Conference Website September 3- 5th: Asia Leaders Conference | Hong Kong | Visit Conference Website September 8- 9th: GS Taiwan AI Tour | Taipei | Visit Conference Website September 8- 11th: Communacopia + Technology Conference | San Francisco | Visit Conference Website September 9- 10th: CEEMEA Financials Symposium | London | Visit Conference Website September 15th: European Real Estate Equity and Debt Conference | London | Visit Conference Website September 16- 17th: European Communacopia Conference | London | Visit Conference Website September 22- 24th: 14th German Corporate Conference 2025 | Munich | Visit Conference Website September 25th: Global Sustainability Forum | New York | Visit Conference Website October 14- 15th: Global Metals and Mining Conference | London | Visit Conference Website",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "0eb33a41282b5da5",
      "text": "Please visit our \"Events\" page for a complete list of conferences and events around the globe",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "d43eef67ef058ca3",
      "text": "Research Unplugged: French confidence vote - what next? with Alex Stott, Simon Freycenet, Sharon Bell, Elias Benzina, Gaelle Jarousse and Sahar Islam Research Unplugged: Unpacking AI from a Generalist Perspective: Latest Abilities, Costs, and More with Alex Duval & Sahar Islam",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "7d9b7b74fb909a68",
      "text": "Research Unplugged: Silicon Valley AI Field Trip Takeaways with Gabriela Borges, George Tong and Chris Hussey Research Unplugged: Exploring Stablecoin Opportunities across Financial Services & FinTech with Will Nance, James Yaro and Chris Hussey Research Unplugged: Updated Treasury Guidance & the Implications for Renewable Energy with Carly Davenport, Brian Singer and Chris Hussey Research Unplugged: European Conviction List - Directors' Cut: August Spotlight with Richard Felton, Richard Edwards, Suhasini Varanasi and Louise Singlehurst; moderated by Jessica Binder Graham & Sahar Islam Research Unplugged: Capex Revival in Europe? - with Sharon Bell, Daniela Costa, Christian Hinderaker and GBM colleagues; moderated by Sahar Islam",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "00e8eb6996aef81d",
      "text": "Please visit the \"Research Unplugged\" page for all podcasts",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "8b39d45f81ae1e9b",
      "text": "China Macro & Strategy: Assessing the 2H Outlook with Hui Shan (GIR), Kinger Lau (GIR) & Himanshu Deshmukh (GBM); moderated by Philip Sun (GBM) | Click here for replayUS Strategy: Hedge Fund & Mutual Fund Positioning with Ryan Hammond (GIR), Jenny Ma (GIR), John (Juhwan) Kim (GBM) | Click here for replayJapan Industrials: What We Learnt from Earnings with Yuichiro Isayama (GIR), Ryo Harada (GIR) & Takeru Adachi (GIR); moderated by Minsu Kim (GBM) | Click here for replayChina Strategy: Anti- involution - Reigniting hopes for profit reflation with Kinger Lau & Si Fu; moderated by Michael Snaith | Click here for replayGS RxChange Series: MoonLake Immunotherapeutics (MLTX) HS Expert's Perspective on SLK's Ph. 3 VELA Expectations and Inverse Dose Response in HS with Dr. Sunaina Rengarajan, Dermatology Physician Scientist at Washington University School Medicine; moderated by Richard Law | Click here for replayEuropean AI & Semis Symposium: AI Power Semis Webcast with Infineon; moderated by Alexander Duval | Click here for replayEurope Hardware & Semis: Assessing the AI landscape in 2025 - Investments, Use Cases and adoption trends - with Eric Sheridan; moderated by Alexander Duval | Click here for replay",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "bf1771fadee1bee4",
      "text": "Please visit our \"Audibles\" page for all of our replays",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "e51349f0b3705216",
      "text": "Subscribe for monthly updates on long- lived research. For the complete library, see our Themes page.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "318988563f36e675",
      "text": "Wise PLC (WISEa.L): Sizable Platforms opportunity underappreciated, embedding Wise deeper into the cross- border money network",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "9c479de6a5cbc40d",
      "text": "2 Sep 2025 | 4:05am| 37pg| Research | Equity- Mohammed Moawalla and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "78e48b6b05bbc220",
      "text": "Geberit Holding (GEBN.S): Reiterate Buy post 2Q; focus on shower toilets",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "1645296f1fe14483",
      "text": "1 Sep 2025 | 10:49pm| 22pg| Research | Equity- Daniela Costa",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "737db7b02b5119b4",
      "text": "VAT Group (VACN.S): Attractive entry point for high- quality semi capex beneficiary: upgrade to Buy",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "167e28967932301b",
      "text": "1 Sep 2025 | 9:34am| 32pg| Research | Equity- Daniela Costa and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "862cf384d32c6027",
      "text": "Konecranes (KCRA.HE): Ports to drive extra returns; Up to Buy",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "454b7946daa761f2",
      "text": "1 Sep 2025 | 9:34am| 30pg| Research | Equity- Daniela Costa and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "6da632b30dc976a6",
      "text": "US Daily: August GSAI: Sticky Near Sixty (Rindels)",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "118ccef5372e1ef7",
      "text": "2 Sep 2025 | 8:41am| 8pg| Research | Economics- Jan Hatzius and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "3120c80377f7b08c",
      "text": "GOAL Kickstart: Summer data- only update",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "00158fd62fbd9da3",
      "text": "2 Sep 2025 | 5:23am| 29pg| Research | Portfolio Strategy- Christian Mueller- Glassmann, CFA and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "8740e8e838e9e9e9",
      "text": "Global Economics Comment: Technical Updates to Our Global CAIs (Singh/Briggs)",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "56ce32fa4b5ac78d",
      "text": "1 Sep 2025 | 1:50pm| 32pg| Research | Economics- Jan Hatzius and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "4053dce17d492d1c",
      "text": "Strategy Matters: Investing in Europe's moment",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "68785843d96525d6",
      "text": "1 Sep 2025 | 9:31am| 14pg| Research | Portfolio Strategy- Sharon Bell and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "16ed9742cc8d736b",
      "text": "European Views: Back to School with Confidence (Stehn)",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "588cea3680768d65",
      "text": "1 Sep 2025 | 7:24am| 10pg| Research | Economics- Sven Jari Stehn and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "13115e888c25c992",
      "text": "Asia in Focus: Liquidity and Inflation Redux - A Roundup of China's Monetary Policy Stance (Chen)",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "409ba9cf6824da81",
      "text": "1 Sep 2025 | 5:49am| 10pg| Research | Economics- Andrew Tilton and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "5157ca4ea12ba7cb",
      "text": "BYD Co. (002594.SZ/1211.HK): 2Q25 Earnings Review: Revenues below expectations and margin miss; expect unit profit to recover in 2H; Buy",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "6567a209705a7165",
      "text": "2 Sep 2025 | 4:34am| 9pg| Research | Equity- Tina Hou and others",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "cc41460824e347bd",
      "text": "Denghai Seeds (002041.SZ): Earnings Review: 1H25A below expectation; Headwind from corn seeds ahead; Downgrade to Sell",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "f8be9064efbb10a9",
      "text": "1 Sep 2025 | 9:08pm | 11pg| Research | Equity- Trina Chen and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "8232da5377ffc947",
      "text": "Australia TMT: Communacopia + Technology 2025: Conference Preview",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "085dfc76938ae6b8",
      "text": "1 Sep 2025 | 2:54pm | 6pg| Research | Equity- Kane Hannan, CFA and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "745592ef8ad58369",
      "text": "A- Living (3319. HK): NI bottoming out; entering stable FCF generation from 2026E onwards; up to Neutral",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "c4c0128a22ca16d0",
      "text": "1 Sep 2025 | 6:31am | 9pg| Research | Equity- Yi Wang, CFA and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "9f6a8a82da184759",
      "text": "AstraZeneca (AZN.L): Baxdrostat Phase 3 data support compelling profile in hypertension to underpin multi- blockbuster sales opportunity",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "4c4696adc72821ee",
      "text": "1 Sep 2025 | 10:00am | 13pg| Research | Equity- Rajan Sharma and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "392ca643a10a1d54",
      "text": "Geberit Holding (GEBN.S): Reiterate Buy post 2Q; focus on shower toilets",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "4c859375551b8be0",
      "text": "1 Sep 2025 | 10:49pm | 22pg| Research | Equity- Daniela Costa",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "73eca2a401528290",
      "text": "VAT Group (VACN.S): Attractive entry point for high- quality semi capex beneficiary; upgrade to Buy",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "fc4ececb353db2ef",
      "text": "1 Sep 2025 | 9:34am | 32pg| Research | Equity- Daniela Costa and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "89196848ab18a58f",
      "text": "Konecranes (KCRA.HE): Ports to drive extra returns; Up to Buy",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "028061d0dbacd31d",
      "text": "1 Sep 2025 | 9:34am | 30pg| Research | Equity- Daniela Costa and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "02e7ab22eb77c247",
      "text": "Wise PLC (WISeA.L): Sizable Platforms opportunity underappreciated, embedding Wise deeper into the cross- border money network",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "95774226fcba8af3",
      "text": "2 Sep 2025 | 4:05am | 37pg| Research | Equity- Mohammed Moawalla and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "d571981e91f081d7",
      "text": "Partners Group (PGHN.S): 1H25 Evergreen update: Weaker inflows and step up in redemptions drive a second quarter of net outflows for Master fund",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "80b405b0c35a7951",
      "text": "1 Sep 2025 | 1:04pm | 7pg| Research | Equity- Oliver Carruthers, CFA and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "816af6fc3b1d9b32",
      "text": "IAG (ICAG.L): Feedback from roadshow",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "54cb6bfec0ca3c61",
      "text": "1 Sep 2025 | 6:58pm | 6pg| Research | Equity- Patrick Creuset and others",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "ee666d87d570d979",
      "text": "I, Sahar lsm, heey certy that ll of the views expressed in this report acurately refect my personal views about the subject company or companies and its or their securitie. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "82dbfcdfda699df3",
      "text": "I, Ayushi Mishra, hereby certify that all of the views expressed in this report accurately reflect my personal views, which have not been influenced by considerations of the firm's business or client relationships.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "85aedf6a484a0509",
      "text": "Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Goldman Sachs' Global Investment Research division.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "d2435455b7c14197",
      "text": "The Goldman Sachs Factor Profile provides investment context for a stock by comparing key attributes to the market (i.e. our universe of rated stocks) and its sector peers. The four key attributes depicted are: Growth, Financial Returns, Multiple (e.g. valuation) and Integrated (a composite of Growth, Financial Returns and Multiple). Growth, Financial Returns and Multiple are calculated by using normalized ranks for specific metrics for each stock. The normalized ranks for the metrics are then averaged and converted into percentiles for the relevant attribute. The precise calculation of each metric may vary depending on the fiscal year, industry and region, but the standard approach is as follows:",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "ab06a60512161a8c",
      "text": "Growth is based on a stock's forward- looking sales growth, EBITDA growth and EPS growth (for financial stocks, only EPS and sales growth), with a higher percentile indicating a higher growth company. Financial Returns is based on a stock's forward- looking ROE, ROCE and CROCI (for financial stocks, only ROE), with a higher percentile indicating a company with higher financial returns. Multiple is based on a stock's forward- looking P/E, P/B, price/ divided (PD), EV/EBITDA, EV/FC and EV/Debt Adjusted Cash Flow (DACF) (for financial stocks, only P/E, P/B and PD), with a higher percentile indicating a stock trading at a higher multiple. The Integrated percentile is calculated as the average of the Growth percentile, Financial Returns percentile and (100% - Multiple percentile).",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "d2dfeab2bfc90b54",
      "text": "Financial Returns and Multiple use the Goldman Sachs analyst forecasts at the fiscal year- end at least three quarters in the future. Growth uses inputs for the fiscal year at least seven quarters in the future compared with the year at least three quarters in the future (on a per- share basis for all metrics).",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "ce1bf7a0d6155fa2",
      "text": "For a more detailed description of how we calculate the GS Factor Profile, please contact your GS representative.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "5f98908d56f0a03c",
      "text": "Across our global coverage, we examine stocks using an M&A framework, considering both qualitative factors and quantitative factors (which may vary across sectors and regions) to incorporate the potential that certain companies could be acquired. We then assign a M&A rank as a means of scoring companies under our rated coverage from 1 to 3, with 1 representing high (30%- 50%) probability of the company becoming an acquisition target, 2 representing medium (15%- 30%) probability and 3 representing low (0%- 15%) probability. For companies ranked 1 or 2, in line with our standard departmental guidelines we incorporate an M&A component into our target price. M&A rank of 3 is considered immaterial and therefore does not factor into our price target, and may or may not be discussed in research.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "b4b2f609452f1e63",
      "text": "Quantum is Goldman Sachs' proprietary database providing access to detailed financial statement histories, forecasts and ratios. It can be used for in- depth analysis of a single company, or to make comparisons between companies in different sectors and markets.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "8eccb7a5a7ed2b9a",
      "text": "See company- specific regulatory disclosures above for any of the following disclosures required as to companies referred to in this report: manager or co- manager in a pending transaction; 1% or other ownership; compensation for certain services; types of client relationships; managed/co- managed public offerings in prior periods; directorships; for equity securities, market making and/or specialist role. Goldman Sachs trades or may trade as a principal in debt securities (or in related derivatives) of issuers discussed in this report.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "71bc96e471d2293e",
      "text": "The following are additional required disclosures: Ownership and material conflicts of interest: Goldman Sachs policy prohibits its analysts, professionals reporting to analysts and members of their households from owning securities of any company in the analyst's area of coverage. Analyst compensation: Analysts are paid in part based on the profitability of Goldman Sachs, which includes investment banking revenues. Analyst as officer or director: Goldman Sachs policy generally prohibits its analysts, persons reporting to analysts or members of their households from serving as an officer, director or advisor of any company in the analyst's area of coverage. Non- U.S. Analysts: Non- U.S. analysts may not be associated persons of Goldman Sachs & Co. LLC and therefore may not be subject to FINRA Rule 2241 or FINRA Rule 2242 restrictions on communications with subject company, public appearances and trading securities held by the analysts.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "5935ec61d8e76c81",
      "text": "Distribution of ratings: See the distribution of ratings disclosure above. Price chart: See the price chart, with changes of ratings and price targets in prior periods, above, or, if electronic format or if with respect to multiple companies which are the subject of this report, on the Goldman Sachs",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "9c34dc57e2fe7cbe",
      "text": "The following disclosures are those required by the jurisdiction indicated, except to the extent already made above pursuant to United States laws and regulations. Australia: Goldman Sachs Australia Pty Ltd and its affiliates are not authorised deposit- taking institutions (as that term is defined in the Banking Act 1959 (Cth)) in Australia and do not provide banking services, nor carry on a banking business, in Australia. This research, and any access to it, is intended only for \"wholesale clients\" within the meaning of the Australian Corporations Act, unless otherwise agreed by Goldman Sachs. In producing research reports, members of Global Investment Research of Goldman Sachs Australia may attend site visits and other meetings hosted by the companies and other entities which are the subject of its research reports. In some instances the costs of such site visits or meetings may be met in part or in whole by the issuers concerned if Goldman Sachs Australia considers it is appropriate and reasonable in the specific circumstances relating to the site visit or meeting. To the extent that the contents of this document contains any financial product advice, it is general advice only and has been prepared by Goldman Sachs without taking into account a client's objectives, financial situation or needs. A client should, before acting on any such advice, consider the appropriateness of the advice having regard to the client's own objectives, financial situation and needs. A copy of certain Goldman Sachs Australia and New Zealand disclosure of interests and a copy of Goldman Sachs' Australian Sell- Side Research Independence Policy Statement are available at: https://www.goldmansachs.com/disclosures/australia- new- zealand/index.html. Brazil: Disclosure information in relation to CVM Resolution n. 20 is available at https://www.gs.com/worldwide/brazil/area/gr/index.html. Where applicable, the Brazil- registered analyst primarily responsible for the content of this research report, as defined in Article 20 of CVM Resolution n. 20, is the first author named at the beginning of this report, unless indicated otherwise at the end of the text. Canada: This information is being provided to you for information purposes only and is not, and under no circumstances should be construed as, an advertisement, offering or solicitation by Goldman Sachs & Co. LLC for purchasers of securities in Canada to trade in any Canadian security. Goldman Sachs & Co. LLC is not registered as a dealer in any jurisdiction in Canada under applicable Canadian securities laws and generally is not permitted to trade in Canadian securities and may be prohibited from selling certain securities and products in certain jurisdictions in Canada. If you wish to trade in any Canadian securities or other products in Canada please contact Goldman Sachs Canada Inc., an affiliate of The Goldman Sachs Group Inc., or another registered Canadian dealer. Hong Kong: Further information on the securities of covered companies referred to in this research may be obtained on request from Goldman Sachs (Asia) L.L.C. India: Further information on the subject company or companies referred to in this research may be obtained from Goldman Sachs (India) Securities Private Limited, Research Analyst - SEBI Registration Number INH000001493, 951- A, Rational House, Apasabeb Marathe Marg, Prabhadevi, Mumbai 400 025, India, Corporate Identity Number U74140MH2006FTC160634, Phone +91 22 6616 9000, Fax +91 22 6616 9001. Goldman Sachs may beneficially own \\(1\\%\\) or more of the securities (as such term is defined in clause 2 (h) the Indian Securities Contracts (Regulation) Act, 1956) of the subject company or companies referred to in this research report. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Goldman Sachs (India) Securities Private Limited compliance officer and investor grievance contact details can be found at this link: https://publishing.gs.com/disclosures/hedge.html - /general/equity. Japan: See below. Korea: This research, and any access to it, is intended only for \"professional investors\" within the meaning of the Financial Services and Capital Markets Act, unless otherwise agreed by Goldman Sachs. Further information on the subject company or companies referred to in this research may be obtained from Goldman Sachs (Asia) L.L.C., Seoul Branch. New Zealand: Goldman Sachs New Zealand Limited and its affiliates are neither \"registered banks\" nor \"deposit takers\" (as defined in the Reserve Bank of New Zealand Act 1989) in New Zealand. This research, and any access to it, is intended for \"wholesale clients\" (as defined in the Financial Advisers Act 2008) unless otherwise agreed by Goldman Sachs. A copy of certain Goldman Sachs Australia and New Zealand disclosure of interests is available at: https://www.goldmansachs.com/disclosures/australia- new- zealand/index.html. Russia: Research reports distributed in the Russian Federation are not advertising as defined in the Russian legislation, but are information and analysis not having product promotion as their main purpose and do not provide appraisal within the meaning of the Russian legislation on appraisal activity. Research reports do not constitute a personalized investment recommendation as defined in Russian laws and regulations, are not addressed to a specific client, and are prepared without analyzing the financial circumstances, investment profiles or risk profiles of clients. Goldman Sachs assumes no responsibility for any investment decisions that may be taken by a client or any other person based on this research report. Singapore: Goldman Sachs (Singapore) Pte. (Company Number: 198602165W), which is regulated by the Monetary Authority of Singapore, accepts legal responsibility for this research, and should be contacted with respect to any matters arising from, or in connection with, this research. Taiwan: This material is for reference only and must not be reprinted without permission. Investors should carefully consider their own investment risk. Investment results are the responsibility of the individual investor. United Kingdom: Persons who would be categorized as retail clients in the United Kingdom, as such term is defined in the rules of the Financial Conduct Authority, should read this research in conjunction with prior Goldman Sachs research on the covered companies referred to herein and should refer to the risk warnings that have been sent to them by Goldman Sachs International. A copy of these risks warnings, and a glossary of certain financial terms used in this report, are available from Goldman Sachs International on request.",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "7216b66f1eaed4c1",
      "text": "European Union and United Kingdom: Disclosure information in relation to Article 6 (2) of the European Commission Delegated Regulation (EU) (2016/958) supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council (including as that Delegated Regulation is implemented into United Kingdom domestic law and regulation following the United Kingdom's departure from the European Union and the European Economic Area) with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommended or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest is available at https://www.gs.com/disclosures/europeanpolicy.html which states the European Policy for Managing Conflicts of Interest in Connection with Investment Research.",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "6cfb62e1b41ae86a",
      "text": "Japan: Goldman Sachs Japan Co., Ltd. is a Financial Instrument Dealer registered with the Kanto Financial Bureau under registration number Kinsho 69, and a member of Japan Securities Dealers Association, Financial Futures Association of Japan Type II Financial Instruments Firms Association, The Investment Trusts Association, Japan, and Japan Investment Advisers Association. Sales and purchase of equities are subject to commission pre- determined with clients plus consumption tax. See company- specific disclosures as to any applicable disclosures required by Japanese stock exchanges, the Japanese Securities Dealers Association or the Japanese Securities Finance Company.",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "47d467733f955946",
      "text": "Buy (B), Neutral (N), Sell (S) Analysts recommend stocks as Buys or Sells for inclusion on various regional Investment Lists. Being assigned a Buy or Sell on an Investment List is determined by a stock's total return potential relative to its coverage universe. Any stock not assigned as a Buy or a Sell on an Investment List with an active rating (i.e., a stock that is not Rating Suspended, Not Rated, Early- Stage Biotech, Coverage Suspended or Not Covered), is deemed Neutral. Each region manages Regional Conviction Lists, which are selected from Buy rated stocks on the respective region's Investment Lists and represent investment recommendations focused on the size of the total return potential and/or the likelihood of the realization of the return across their respective areas of coverage. The addition or removal of stocks from such Conviction Lists are managed by the Investment Review Committee or other designated committee in each respective region and do not represent a change in the analysts' investment rating for such stocks.",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "08341daa63955bfd",
      "text": "Total return potential represents the upside or downside differential between the current share price and the price target, including all paid or anticipated dividends, expected during the time horizon associated with the price target. Price targets are required for all covered stocks. The total return potential, price target and associated time horizon are stated in each report adding or reiterating an Investment List membership.",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "1e41117932fc824a",
      "text": "Coverage Universe: A list of all stocks in each coverage universe is available by primary analyst, stock and coverage universe at",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "43fcd0ba63ffeca9",
      "text": "https://www.gs.com/research/hedge.html",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "20629aa3ae6d1baf",
      "text": "Not Rated (NR). The investment rating, target price and earnings estimates (where relevant) are removed pursuant to Goldman Sachs policy when Goldman Sachs is acting in an advisory capacity in a merger or in a strategic transaction involving this company, when there are legal, regulatory or policy constraints due to Goldman Sachs' involvement in a transaction, and in certain other circumstances. Early- Stage Biotech (ES). An investment rating and a target price are not assigned pursuant to Goldman Sachs policy when this company neither has a drug, treatment or medical device that has passed a Phase II clinical trial nor a license to distribute a post- Phase II drug, treatment or medical device. Rating Suspended (RS). Goldman Sachs Research has suspended the investment rating and price target for this stock, because there is not a sufficient fundamental basis for determining an investment rating or target price. The previous investment rating and target price, if any, are no longer in effect for this stock and should not be relied upon. Coverage Suspended (CS). Goldman Sachs has suspended coverage of this company. Not Covered (NC). Goldman Sachs does not cover this company.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "e734209a2e2a4d65",
      "text": "Goldman Sachs International (\"GSI\"), authorised by the Prudential Regulation Authority (\"PRA\") and regulated by the Financial Conduct Authority (\"FCA\") and the PRA, has approved this research in connection with its distribution in the United Kingdom.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "cbc46df9f5c9e956",
      "text": "European Economic Area: GSI, authorised by the PRA and regulated by the FCA and the PRA, disseminates research in the following jurisdictions within the European Economic Area: the Grand Duchy of Luxembourg, Italy, the Kingdom of Belgium, the Kingdom of Denmark, the Kingdom of Norway, the Republic of Finland and the Republic of Ireland; GSI - Succursale de Paris (Paris branch) which is authorised by the French Autorite de controle prudentiel et de resolution (\"ACPR\") and regulated by the Autorite de controle prudentiel et de resolution and the Autorite des marches financiers (\"AMF\") disseminates research in France; GSI - Sucursal en Espana (Madrid branch) authorized in Spain by the Comision Nacional del Mercado de Valores disseminates research in the Kingdom of Spain; GSI - Sweden Bankfall (Stockholm branch) is authorized by the SFSA as a \"third country branch\" in accordance with Chapter 4, Section 4 of the Swedish Securities and Market Act (Sw. lag (2007:528) om vardepappersmarknaden) disseminates research in the Kingdom of Sweden; Goldman Sachs Bank Europe SE (\"GSBE\") is a credit institution incorporated in Germany and, within the Single Supervisory Mechanism, subject to direct prudential supervision by the European Central Bank and in other respects supervised by German Federal Financial Supervisory Authority (Bundesanstalt fur Finanzdienstleistungsaufsicht, BaFin) and Deutsche Bundesbank and disseminates research in the Federal Republic of Germany and those jurisdictions within the European Economic Area where GSI is not authorised to disseminate research and additionally, GSBE, Copenhagen Branch filial of GSBE, Tyskland, supervised by the Danish Financial Authority disseminates research in the Kingdom of Denmark; GSBE - Sucursal en Espana (Madrid branch) subject to a limited extent) to local supervision by the Bank of Spain disseminates research in the Kingdom of Spain; GSBE - Sucursale Italia (Milan branch) to the relevant applicable extent, subject to local supervision by the Bank of Italy (Banca d'Italia) and the Italian Companies and Exchange Commission (Commissione Nazionale per le Societa e la Borsa \"Consob\") disseminates research in Italy; GSBE - Sucursale de Paris (Paris branch), supervised by the AMF and by the ACPR disseminates research in France; and GSBE - Sweden Bankfall (Stockholm branch), to a limited extent, subject to local supervision by the Swedish Financial Supervisory Authority (Finansinspektionen) disseminates research in the Kingdom of Sweden.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "aaf2633d6da348f8",
      "text": "This research is for our clients only. Other than disclosures relating to Goldman Sachs, this research is based on current public information that we consider reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. The information, opinions, estimates and forecasts contained herein are as of the date hereof and are subject to change without prior notification. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Other than certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the analyst's judgment.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "153618a1db87a976",
      "text": "Goldman Sachs conducts a global full- service, integrated investment banking, investment management, and brokerage business. We have investment banking and other business relationships with a substantial percentage of the companies covered by Global Investment Research. Goldman Sachs & Co. LLC, the United States broker dealer, is a member of SIPC (https://www.sipc.org).",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "acfe249013ee0289",
      "text": "Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and principal trading desks that reflect opinions that are contrary to the opinions expressed in this research. Our asset management area, principal trading desks and investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "d87bb9afd2005ae2",
      "text": "The analysts named in this report may have from time to time discussed with our clients, including Goldman Sachs salespersons and traders, or may discuss in this report, trading strategies that reference catalysts or events that may have a near- term impact on the market price of the equity securities discussed in this report, which impact may be directionally counter to the analyst's published price target expectations for such stocks. Any such trading strategies are distinct from and do not affect the analyst's fundamental equity rating for such stocks, which rating reflects a stock's return potential relative to its coverage universe as described herein.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "0cca1d8749b3b962",
      "text": "We and our affiliates, officers, directors, and employees will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives, if any, referred to in this research, unless otherwise prohibited by regulation or Goldman Sachs policy.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "7df35fa6bb47794d",
      "text": "The views attributed to third party presenters at Goldman Sachs arranged conferences, including individuals from other parts of Goldman Sachs, do not necessarily reflect those of Global Investment Research and are not an official view of Goldman Sachs.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "0b42aeab8c2d1ba0",
      "text": "Any third party referenced herein, including any salespeople, traders and other professionals or members of their household, may have positions in the products mentioned that are inconsistent with the views expressed by analysts named in this report.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "ab668cb6411d74a7",
      "text": "This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this research is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of investments referred to in this research and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur.",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "32cb1a7dbdbb7c87",
      "text": "Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "720c0f79eedfeb72",
      "text": "Certain transactions, including those involving futures, options, and other derivatives, give rise to substantial risk and are not suitable for all investors. Investors should review current options and futures disclosure documents which are available from Goldman Sachs sales representatives or at https://www.theocc.com/about/publications/character- risks.jsp and https://www.goldmansachs.com/disclosures/cftc_fcm_disclosures. Transaction costs may be significant in option strategies calling for multiple purchase and sales of options such as spreads. Supporting documentation will be supplied upon request.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "017feb05ef82db94",
      "text": "Differing Levels of Service provided by Global Investment Research: The level and types of services provided to you by Goldman Sachs Global Investment Research may vary as compared to that provided to internal and other external clients of GS, depending on various factors including your individual preferences as to the frequency and manner of receiving communication, your risk profile and investment focus and perspective (e.g., marketwide, sector specific, long term, short term), the size and scope of your overall client relationship with GS, and legal and regulatory constraints. As an example, certain clients may request to receive notifications when research on specific securities is published, and certain clients may request that specific data underlying analysts' fundamental analysis available on our internal client websites be delivered to them electronically through data feeds or otherwise. No change to an analyst's fundamental research views (e.g., ratings, price targets, or material changes to earnings estimates for equity securities), will be communicated to any client prior to inclusion of such information in a research report broadly disseminated through electronic publication to our internal client websites or through other means, as necessary, to all clients who are entitled to receive such reports.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "fd0c87d601d6a84e",
      "text": "All research reports are disseminated and available to all clients simultaneously through electronic publication to our internal client websites. Not all research content is redistributed to our clients or available to third- party aggregators, nor is Goldman Sachs responsible for the redistribution of our research by third party aggregators. For research, models or other data related to one or more securities, markets or asset classes (including related services) that may be available to you, please contact your GS representative or go to https://research.gs.com.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "484fb9e9f6381690",
      "text": "Disclosure information is also available at https://www.gs.com/research/hedge.html or from Research Compliance, 200 West Street, New York, NY 10282.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "d058cf8c38d0bfe4",
      "text": "You are permitted to store, display, analyze, modify, reformat, and print the information made available to you via this service only for your own use. You may not resell or reverse engineer this information to calculate or develop any index for disclosure and/or marketing or create any other derivative works or commercial product(s), data or offering(s) without the express written consent of Goldman Sachs. You are not permitted to publish, transmit, or otherwise reproduce this information, in whole or in part, in any format to any third party without the express written consent of Goldman Sachs. This foregoing restriction includes, without limitation, using, extracting, downloading or retrieving this information, in whole or in part, to train or finetune a machine learning or artificial intelligence system, or to provide or reproduce this information, in whole or in part, as a prompt or input to any such system.",
      "page": 12,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "eab63b975116350b",
      "name": "AI Field",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "5a28bd7e24a3ea3d",
      "name": "AI Power",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "470705662f19174b",
      "name": "AI Tour",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "bfd8bc80acfd4fcd",
      "name": "APAC Conviction",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6afac77b7140b4ce",
      "name": "Advisers Association",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "b60c80d8aa60e58a",
      "name": "Airlines Group",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "91f18b91de5fdb6b",
      "name": "Ajay Patel",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "163c4e4833c1e27e",
      "name": "Alex Duval",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "daf4c6cbaa247951",
      "name": "Alex Stott",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "292cb6e51e914cd3",
      "name": "Alexander Duval",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "5dd440bb101d6630",
      "name": "Andrew Tilton",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "169555e57e10b143",
      "name": "Andrew Tilton and others\n\nAsia Equity\n\nBYD Co",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "bab70d449cc643ea",
      "name": "Annual EMEA",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "dec9e2b362b2d7f2",
      "name": "Annual Global",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "89afa40d3b2c764a",
      "name": "Apasabeb Marathe",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "3a3bdcdaea9b4e73",
      "name": "Asia Equity",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "0ef78d5c5e896679",
      "name": "Asia Leaders",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "32ef07cbda94c674",
      "name": "August GSAI",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "a78a237f6a7c2e56",
      "name": "August Spotlight",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6d4488d766412406",
      "name": "Australia Pty",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "other",
        "title": "GS Insights On The Go",
        "page": 6,
        "axes": {},
        "series": [],
        "figure_id": "e9651cc35609a6e8",
        "provenance": {
          "page": 6
        }
      },
      {
        "type": "other",
        "title": "MINDRAFT GS Research's Theme Bookshelf",
        "page": 7,
        "axes": null,
        "series": [],
        "figure_id": "d7f90484dc325cb3",
        "provenance": {
          "page": 7
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "07f8cb75a934127a",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ees a recovery in Industrial Equipment over the medium term driven by German infrastructure spend (c20% of revenues). Strong cash generation supports increased returns with a total yield of c7%. Wise ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "172825e006357cd4",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "spend (c20% of revenues). Strong cash generation supports increased returns with a total yield of c7%. Wise PLC (WISEA.L) - sizable Platforms opportunity underappreciated; Buy, on Conviction List - Mo",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "1ae4b07d75d855f6",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "wo upside scenarios assume 1) mid- term upside where he sees a faster ramp of existing partners (6- 14% PBT accretion vs base case 2026- 2030), and 2) long- term upside scenario where he assumes the f",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "d04cce7d6253036f",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ong- term upside scenario where he assumes the faster ramp of existing plus future wins 2040E (c12- 30% PBT accretion). Mo's base case is already c5- 20% ahead of<ï½œendâ–ofâ–sentenceï½œ>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3ea5c608d32b96a2",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ter ramp of existing plus future wins 2040E (c12- 30% PBT accretion). Mo's base case is already c5- 20% ahead of<ï½œendâ–ofâ–sentenceï½œ>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "40955563e7c86d53",
        "value": 7.0,
        "unit": "â‚¬",
        "metric_type": "currency",
        "context": ", Vestas Wind Systems and Konecranes to the Conviction List while removing L'Oreal. UCB: Bimzelx (câ‚¬7bn peak sales, \\(12\\%\\) ahead of consensus) is a rare opportunity within European Biopharma to own ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "7e1b8ed4719972c7",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "t a reverse DCF to estimate that the share price is discounting low teens sales growth (vs. GSe of c16%) over the next decade which he thinks is undemanding. The Wise Connect event is the next catalys",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "b66162c33a08c3c9",
        "value": 0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "the next catalyst to further support its healthy pipeline and more detail on recent wins. Buy with c45%+ upside. ## Geberit Holding (GEBN.S) - shower toilets to drive sizeable gross margin expansion w",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "bbdeb0e46b63ec75",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "te on shower toilets). Minor estimate adjustments post 2Q results \\(< 1\\%\\) 2025- 27E EPS) and is c.3% above consensus on FY25/26 adj. EBITDA. Buy. Europe Rating Changes - None <table><tr><td colspan=",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "33911043011281c4",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/26 adj. EBITDA. Buy. Europe Rating Changes - None <table><tr><td colspan=\"5\">Europe EPS Changes (5% or more)</td></tr><tr><td>Company Name</td><td>Forecast Year</td><td>EPS % change</td><td>Rating</t",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "34d840cd73c8fe2b",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ange</td><td>Rating</td><td>Price as of last close</td></tr><tr><td>BioArctic</td><td>2025E</td><td>9.0%</td><td>Buy</td><td>Skr 309</td></tr><tr><td>As of 5 AM UKT</td><td>2026E</td><td>30.0%</td><td",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "d9dc161ed7caef57",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "025E</td><td>9.0%</td><td>Buy</td><td>Skr 309</td></tr><tr><td>As of 5 AM UKT</td><td>2026E</td><td>30.0%</td><td></td><td></td></tr></table> Source: Goldman Sachs Global Investment Research ## Other ",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "0b114a098f64b409",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r collaboration with Novartis provides additional step toward platform validation; updated PT with c14% upside; Buy ## Macro / markets Global Weekly Kickstart - Markets stall as French politics weigh ",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "7de37a0e789e66ad",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s stall as French politics weigh on Europe - Global equities were flat last week and Europe fell by 2% on political uncertainty in France. The CAC dropped 3.3%, reflecting concerns of a potential Fren",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "19643564c144d364",
        "value": 0.033,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ities were flat last week and Europe fell by 2% on political uncertainty in France. The CAC dropped 3.3%, reflecting concerns of a potential French government collapse in the<ï½œendâ–ofâ–sentenceï½œ>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "bf6f5bf427641d2a",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "percentile is calculated as the average of the Growth percentile, Financial Returns percentile and (100% - Multiple percentile). Financial Returns and Multiple use the Goldman Sachs analyst forecasts ",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "1435a9dbd410a5ba",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ank as a means of scoring companies under our rated coverage from 1 to 3, with 1 representing high (30%- 50%) probability of the company becoming an acquisition target, 2 representing medium (15%- 30%",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "060ec48fe079f819",
        "value": 0.5,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s a means of scoring companies under our rated coverage from 1 to 3, with 1 representing high (30%- 50%) probability of the company becoming an acquisition target, 2 representing medium (15%- 30%) pro",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "7cb21fc6abdf1109",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "g high (30%- 50%) probability of the company becoming an acquisition target, 2 representing medium (15%- 30%) probability and 3 representing low (0%- 15%) probability. For companies ranked 1 or 2, in ",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "d5d68f0e76e75b3e",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "h (30%- 50%) probability of the company becoming an acquisition target, 2 representing medium (15%- 30%) probability and 3 representing low (0%- 15%) probability. For companies ranked 1 or 2, in line ",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "6850783d48711964",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ecoming an acquisition target, 2 representing medium (15%- 30%) probability and 3 representing low (0%- 15%) probability. For companies ranked 1 or 2, in line with our standard departmental guidelines",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "8ae33ad89cf7ea4f",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ing an acquisition target, 2 representing medium (15%- 30%) probability and 3 representing low (0%- 15%) probability. For companies ranked 1 or 2, in line with our standard departmental guidelines we ",
        "provenance": {
          "page": 9
        }
      },
      {
        "num_id": "955d757ff61cd1d2",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "quired as to companies referred to in this report: manager or co- manager in a pending transaction; 1% or other ownership; compensation for certain services; types of client relationships; managed/co-",
        "provenance": {
          "page": 9
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 2,
      "tables_count": 0,
      "numerical_data_count": 23,
      "passages_count": 116,
      "entities_count": 20
    }
  }
}